BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 27341831)

  • 1. Cholesterol Sulfonation Enzyme, SULT2B1b, Modulates AR and Cell Growth Properties in Prostate Cancer.
    Vickman RE; Crist SA; Kerian K; Eberlin L; Cooks RG; Burcham GN; Buhman KK; Hu CD; Mesecar AD; Cheng L; Ratliff TL
    Mol Cancer Res; 2016 Sep; 14(9):776-86. PubMed ID: 27341831
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cholesterol Sulfotransferase SULT2B1b Modulates Sensitivity to Death Receptor Ligand TNFα in Castration-Resistant Prostate Cancer.
    Vickman RE; Yang J; Lanman NA; Cresswell GM; Zheng F; Zhang C; Doerge RW; Crist SA; Mesecar AD; Hu CD; Ratliff TL
    Mol Cancer Res; 2019 Jun; 17(6):1253-1263. PubMed ID: 30824526
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of SULT2B1b expression alters effects of 3beta-hydroxysteroids on cell proliferation and steroid hormone receptor expression in human LNCaP prostate cancer cells.
    He D; Falany CN
    Prostate; 2007 Sep; 67(12):1318-29. PubMed ID: 17626250
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibitory Interplay of SULT2B1b Sulfotransferase with AKR1C3 Aldo-keto Reductase in Prostate Cancer.
    Park S; Song CS; Lin CL; Jiang S; Osmulski PA; Wang CM; Marck BT; Matsumoto AM; Morrissey C; Gaczynska ME; Chen Y; Mostaghel EA; Chatterjee B
    Endocrinology; 2020 Feb; 161(2):. PubMed ID: 31894239
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distinct expression patterns of SULT2B1b in human prostate epithelium.
    Yang J; Broman MM; Cooper PO; Lanman NA; Strand DW; Morrissey C; Ratliff TL
    Prostate; 2019 Aug; 79(11):1256-1266. PubMed ID: 31212370
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cholesterol sulfate and cholesterol sulfotransferase inhibit gluconeogenesis by targeting hepatocyte nuclear factor 4α.
    Shi X; Cheng Q; Xu L; Yan J; Jiang M; He J; Xu M; Stefanovic-Racic M; Sipula I; O'Doherty RM; Ren S; Xie W
    Mol Cell Biol; 2014 Feb; 34(3):485-97. PubMed ID: 24277929
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SULT2B1b sulfotransferase: induction by vitamin D receptor and reduced expression in prostate cancer.
    Seo YK; Mirkheshti N; Song CS; Kim S; Dodds S; Ahn SC; Christy B; Mendez-Meza R; Ittmann MM; Abboud-Werner S; Chatterjee B
    Mol Endocrinol; 2013 Jun; 27(6):925-39. PubMed ID: 23579488
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A regulatory feedback loop between Ca2+/calmodulin-dependent protein kinase kinase 2 (CaMKK2) and the androgen receptor in prostate cancer progression.
    Karacosta LG; Foster BA; Azabdaftari G; Feliciano DM; Edelman AM
    J Biol Chem; 2012 Jul; 287(29):24832-43. PubMed ID: 22654108
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The PPARγ ligand ciglitazone regulates androgen receptor activation differently in androgen-dependent versus androgen-independent human prostate cancer cells.
    Moss PE; Lyles BE; Stewart LV
    Exp Cell Res; 2010 Dec; 316(20):3478-88. PubMed ID: 20932825
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Androgen ablation elicits PP1-dependence for AR stabilization and transactivation in prostate cancer.
    Liu X; Han W; Gulla S; Simon NI; Gao Y; Liu J; Wang L; Yang H; Zhang X; Chen S
    Prostate; 2016 May; 76(7):649-61. PubMed ID: 26847655
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel crosstalk between the tumor suppressors ING1 and ING2 regulates androgen receptor signaling.
    Esmaeili M; Pungsrinont T; Schaefer A; Baniahmad A
    J Mol Med (Berl); 2016 Oct; 94(10):1167-1179. PubMed ID: 27305909
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The immunophilin ligands cyclosporin A and FK506 suppress prostate cancer cell growth by androgen receptor-dependent and -independent mechanisms.
    Periyasamy S; Warrier M; Tillekeratne MP; Shou W; Sanchez ER
    Endocrinology; 2007 Oct; 148(10):4716-26. PubMed ID: 17615153
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proteasome-associated deubiquitinase ubiquitin-specific protease 14 regulates prostate cancer proliferation by deubiquitinating and stabilizing androgen receptor.
    Liao Y; Liu N; Hua X; Cai J; Xia X; Wang X; Huang H; Liu J
    Cell Death Dis; 2017 Feb; 8(2):e2585. PubMed ID: 28151478
    [TBL] [Abstract][Full Text] [Related]  

  • 14. GLUT12 promotes prostate cancer cell growth and is regulated by androgens and CaMKK2 signaling.
    White MA; Tsouko E; Lin C; Rajapakshe K; Spencer JM; Wilkenfeld SR; Vakili SS; Pulliam TL; Awad D; Nikolos F; Katreddy RR; Kaipparettu BA; Sreekumar A; Zhang X; Cheung E; Coarfa C; Frigo DE
    Endocr Relat Cancer; 2018 Apr; 25(4):453-469. PubMed ID: 29431615
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The tumor suppressor ING1b is a novel corepressor for the androgen receptor and induces cellular senescence in prostate cancer cells.
    Esmaeili M; Jennek S; Ludwig S; Klitzsch A; Kraft F; Melle C; Baniahmad A
    J Mol Cell Biol; 2016 Jun; 8(3):207-20. PubMed ID: 26993046
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The NLR-related protein NWD1 is associated with prostate cancer and modulates androgen receptor signaling.
    Correa RG; Krajewska M; Ware CF; Gerlic M; Reed JC
    Oncotarget; 2014 Mar; 5(6):1666-82. PubMed ID: 24681825
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of Cholesterol Sulfotransferase SULT2B1b by Hepatocyte Nuclear Factor 4α Constitutes a Negative Feedback Control of Hepatic Gluconeogenesis.
    Bi Y; Shi X; Zhu J; Guan X; Garbacz WG; Huang Y; Gao L; Yan J; Xu M; Ren S; Ren S; Liu Y; Ma X; Li S; Xie W
    Mol Cell Biol; 2018 Apr; 38(7):. PubMed ID: 29378829
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protein arginine methyltransferase 5 functions as an epigenetic activator of the androgen receptor to promote prostate cancer cell growth.
    Deng X; Shao G; Zhang HT; Li C; Zhang D; Cheng L; Elzey BD; Pili R; Ratliff TL; Huang J; Hu CD
    Oncogene; 2017 Mar; 36(9):1223-1231. PubMed ID: 27546619
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacological inhibition of androgen receptor expression induces cell death in prostate cancer cells.
    Song IS; Jeong YJ; Kim J; Seo KH; Baek NI; Kim Y; Kim CS; Jang SW
    Cell Mol Life Sci; 2020 Nov; 77(22):4663-4673. PubMed ID: 31894360
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PYK2 via S6K1 regulates the function of androgen receptors and the growth of prostate cancer cells.
    Hsiao YH; Huang YT; Hung CY; Kuo TC; Luo FJ; Yuan TC
    Endocr Relat Cancer; 2016 Aug; 23(8):651-63. PubMed ID: 27492635
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.